Current News Friday, January 27, 2012
Anglo American Lends its Expertise to Business Leadership Council for a Generation Born HIV Free
Anglo American Lends its Expertise to Business Leadership Council for a Generation Born HIV Free... more
Co-Chair Announced for 4th Annual Forum for Payers on Personalized Medicine -- Dr. Bryan Loy, Physician Lead, Cancer; Vice President, Market Medical Officer, Humana
Co-Chair Announced for 4th Annual Forum for Payers on Personalized Medicine -- Dr. Bryan Loy,... more
iBio, Inc. Listing Deficiency Resolved
iBio, Inc. Listing Deficiency Resolved
PR Newswire
NEWARK, Del., Jan. 27, 2012... more
Elekta Demonstrates Comprehensive Range of Cancer Management Solutions at 2012 Arab Health Congress and Exhibition
Elekta Demonstrates Comprehensive Range of Cancer Management Solutions at 2012 Arab Health... more
Lee & Low Books Acquires Children's Book Press Assets
Lee & Low Books Acquires Children's Book Press Assets
--Continues Expansion in Recessionary... more
Honda Announces Pricing for New Four-cylinder 2012 Honda Crosstour
Honda Announces Pricing for New Four-cylinder 2012 Honda Crosstour
Starting at $27,655,... more
Disney-Style Salute Planned for Fifth-Year Anniversary as 100 Students are Selected for Disney's Dreamers Academy
Disney-Style Salute Planned for Fifth-Year Anniversary as 100 Students are Selected for Disney's... more
Free Resources on Scholastic.com Help Teachers Explore Black History Month in the Classroom
Free Resources on Scholastic.com Help Teachers Explore Black History Month in the Classroom... more
LEO Pharma Announces That Picato® (ingenol mebutate) gel has Been Approved by US FDA for Once-Daily, 2 or 3 day Treatment of Actinic Keratoses
LEO Pharma Announces That Picato® (ingenol mebutate) gel has Been Approved by US FDA for... more
Interventional Spine, Inc. Announces FDA Clearance of its Opticage? Expandable Interbody for Treatment of Degenerative Disc Disease
Interventional Spine, Inc. Announces FDA Clearance of its Opticage? Expandable Interbody for... more
FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK)... more
Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins
Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core... more
| 
